Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-C000000046
JPRN-C000000046
Completed
未知

A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204) - Percutaneous radiofrequency ablation for intrapelvic tumor (JIVROSG-0204)

Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 sites33 target enrollmentAugust 6, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSymptomatic intrapelvic malignant tumor

Overview

Phase
未知
Intervention
Not specified
Conditions
Symptomatic intrapelvic malignant tumor
Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Enrollment
33
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2005
End Date
September 22, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\) No symptom or VAS of less than 3\. 2\) Cardiac pacemaker. 3\) Artery or nerve along the puncture route. 4\) Lesion or target area adjacent to critical organs. 5\) Infection in the target area. 6\) Pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A phase I/II study of percutaneous radiofrequency ablation for osteoid osteoma (JIVROSG-0704)osteoid osteoma
JPRN-UMIN000001501Japan Interventional Radiology in Oncology Study Group (JIVROSG)21
Completed
Phase 1
A phase I/II study of percutaneous radiofrequency ablation for metastatic bone tumor (JIVROSG-0208)Symptomatic metastatic bone tumor
JPRN-C000000047Japan Interventional Radiology in Oncology Study Group (JIVROSG)33
Completed
Phase 2
A phase II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0702)Malignant lung tumor
JPRN-UMIN000001502Japan Interventional Radiology in Oncology Study Group (JIVROSG)33
Completed
Phase 1
A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)malignant renal tumor
JPRN-UMIN000001123Japan Interventional Radiology in Oncology Study Group (JIVROSG)33
Recruiting
Not Applicable
Evaluation of safety of percutaneous radiofrequency ablation therapy for metastatic or primary lung cancerprimary or metastatic lung cancer
JPRN-UMIN000005957Oita University Faculty of Medicine, Department of Radiology20